The incorporation of plant-derived oils into cosmetic formulations has attracted increasing interest due to their natural origin, skin compatibility, and multifunctional formulation roles. Argan and castor oils are widely used in cosmetic products as emollient lipid components with intrinsic antioxidant properties. However, limited studies have systematically evaluated the physicochemical stability and antioxidant performance of emulsions combining these two oils. The aim of this study was to develop and comprehensively characterize a stable oil-in-water (O/W) cosmetic emulsion based on argan and castor oils using a natural non-ionic emulsifier (C14–22 Alcohol (and) C12–20 Alkyl Glucoside). Particular emphasis was placed on formulation stability, as it represents a critical prerequisite for further product evaluation. Stability was investigated through thermal stress testing (4–37 °C), centrifugation assays, droplet size analysis, and zeta potential measurements. Complementary physicochemical and structural characterization was performed using rheological analysis and Fourier transform infrared (FT-IR) spectroscopy. The formulated emulsion exhibited good physical stability with no phase separation under the tested conditions, a skin-compatible pH, a uniform droplet size distribution (4.15 ± 0.68 µm), and pseudoplastic, moderately thixotropic rheological behavior. Antioxidant capacity was assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, yielding an IC₅₀ value of 19.21 ± 1.02 mg/mL. Overall, this study provides a formulation-oriented framework for the development and evaluation of stable natural oil-based O/W emulsions intended for cosmetic applications, supporting future optimization and biological validation.

Primary hepatic gastrointestinal stromal tumours (PHGISTs) are rare and frequently misdiagnosed due to their atypical presentation and uncertain origin. The purpose of this article is to present the case of a 79-year-old female patient with a gigantic PHGIST characterized by a predominantly cystic nature—an extremely rare presentation, as most cases of PHGIST are solid. Despite extensive imaging and exploratory laparotomy, the primary origin remained uncertain, leading to questioning about whether it was a true primary hepatic GIST or an atypical metastatic lesion. The initial therapeutic approach involved a surgical procedure aimed to confirm the diagnosis and achieve reductive tumourectomy. Following the surgery, the patient was administered imatinib with a favourable clinical response for four and a half years—an atypical pattern of resistance, as most patients typically develop therapeutic resistance within two to three years. A second surgical intervention was performed to address a cystic lesion localized in the left hepatic lobe, followed by an atypical segment III hepatectomy to achieve macroscopic resection. Subsequently, the patient received sunitinib for two and a half years, which resulted in temporary disease stabilization. However, the sunitinib treatment was associated with hypertension and leukopenia. The patient’s overall survival was 8 years, suggesting that individualized therapeutic strategies and close monitoring might be the key in such cases. Furthermore, this case confirms the role of surgical intervention even in advanced disease stages, with multiple major resections contributing significantly to prolonged survival. The interplay between surgical and oncologic therapies remains essential to guiding clinical decisions. Given the unusual cystic presentation, this case highlights the necessity to expand the pathological and molecular profiling of PHGISTs. Furthermore, the atypical timeline of resistance development and treatment-related toxicity emphasizes the importance of further research into the genetic and pharmacological determinants of PHGISTs. These findings advocate for the refinement of diagnostic, therapeutic, and surveillance protocols tailored to rare GIST subtypes.

This study provides a comparative chemical and antioxidant characterization of two Arabica coffee varieties, one originating from the Dominican Republic and one processed as a multicomponent blend in Romania. Qualitative analyses confirmed the presence of alkaloids and caffeine in all samples. Spectrophotometric determinations revealed that hot-water infusions exhibited higher total polyphenol and flavonoid contents compared to cold-brew extracts. Heavy-metal analysis indicated low levels of cadmium and lead, demonstrating satisfactory sanitary quality. Antioxidant evaluation showed strong radical-scavenging activity in the DPPH assay (88.11–88.98%) with minimal variation between extraction methods. In contrast, the FRAP assay highlighted significant differences influenced by both geographical origin and extraction technique, with reducing capacities ranging from 868 to 1062 μmol Fe²⁺/g. These findings underline the substantial antioxidant potential of Arabica coffee and emphasize the combined role of origin-dependent phytochemical variability and extraction parameters in determining its functional properties.